The Ministry emphasized that all vaccines used in the country as part of the National Immunization Schedule undergo multiple stages of both international and national expertise. They are registered and approved for use in accordance with the requirements of the World Health Organization and the legislation of Kazakhstan.
The procurement of vaccines is carried out exclusively based on criteria of quality, safety, and efficacy, rather than on the principle of low cost.
Claims that vaccines "cause diseases in children" have no scientific basis and contradict the results of many years of international research, the statement notes.
The Ministry of Health also reported that over 34 years of implementing the National Immunization Policy in Kazakhstan, there has been a significant reduction in morbidity:
- epidemic mumps — more than 100 times (from 12,194 cases in 1990 to 118 cases in 2024);
- viral hepatitis A — more than 32 times (from 73,962 cases in 1990 to 2,289 cases in 2024);
- viral hepatitis B — 92 times (from 5,287 in 1990 to 57 cases in 2024).
As a result of vaccination, the incidence of measles among children has decreased by more than 90%, rubella and mumps by 95%, and no cases of poliomyelitis have been recorded since 1996, and diphtheria since 2009.
